company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,959000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1813000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,561000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2647000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2647000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-289000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1501000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,239000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,94000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,94000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,94000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-743000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1145000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1705000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1788000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-302000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,217000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,914000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,914000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,249000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,402000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,402000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,682000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,904000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2293000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3468000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-463000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5464000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5464000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,73000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,73000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,73000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-430000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,42000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1772000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1772000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,940000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1835000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-857000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,146000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,146000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1501000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-251000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-251000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,645000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,805000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,805000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,938000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1638000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1046000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7511000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8556000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8556000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-472000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7629000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7629000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7629000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,220000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1680000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1079000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2098000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1512000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2266000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2266000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-665000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1165000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1165000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,197000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,171000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,368000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,368000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-282000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1187000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,958000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1479000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-427000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1017000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8784000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8784000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,103000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3883000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3986000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3986000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-379000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1253000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2679000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1506000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4993000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,192000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,123000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2574000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-234000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,898000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,17000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,842000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2939000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2582000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-470000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6470000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6470000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1228000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,990000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,990000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,607000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2628000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1890000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8403000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8403000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1265000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1535000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1535000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,562000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,508000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,637000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2265000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2123000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5502000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9049000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9049000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10654000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,246000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10408000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10408000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-90000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6260000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,75000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,637000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2884000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,295000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-764000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25177000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4441000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4441000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,285000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-60000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3928000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3928000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-495000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1306000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,56000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,652000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4143000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3105000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-711000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16151000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17750000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,888000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,888000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-426000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1505000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1505000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-84000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2276000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,798000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,670000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3128000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,298000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-525000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18448000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10973000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,426000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,312000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3699000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3699000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,512000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1607000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,72000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,541000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1748000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1767000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8449000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1065000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24481000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26514000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,968000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,968000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2909000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2909000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2909000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,186000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12512000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,236000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,645000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4258000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1370000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-460000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16001000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,385000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1134000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1519000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1519000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,25000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1716000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,218000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,621000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4527000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-249000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3190000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3190000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-380000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24524000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35730000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13824000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,575000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4373000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2075000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6712000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6712000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15697000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21146000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25799000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25799000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,397000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1740000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2137000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2137000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-307000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17257000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4974000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3133000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-736000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27991000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18727000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18727000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6064000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6064000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6064000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-467000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,791000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,98874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,98874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,974000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4266000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-85851000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18263000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18263000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2956000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13640000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16163000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16163000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,398000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1117000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1515000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1515000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-692000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2923000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,663000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3588000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10914000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10914000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42661000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50263000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5739000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5739000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1205000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18030000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,274000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,689000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11163000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1645000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17942000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17942000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1556000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57091000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51190000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7457000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7457000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3339000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3785000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3785000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-280000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13990000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,302000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6534000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7431000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,25382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,25382000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4514000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-90593000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-26365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-26365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,273000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,273000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,273000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-485000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,148000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1063000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4945000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,22557000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,22557000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7691000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-71380000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,49444000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29627000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29627000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1892000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1892000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,183000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12910000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12910000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1406000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8033000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4031000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,26380000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,26380000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5099000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-67318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,47090000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25327000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25327000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11222000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,212000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9957000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,420000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1552000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7724000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-795000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17356000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17356000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5354000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-66917000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69595000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2676000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2676000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-83000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,769000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1009000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1695000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1695000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,60000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16435000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,89000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1530000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6216000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10947000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,34125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,34125000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13586000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-43505000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27985000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29106000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29106000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-181000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3175000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1653000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6360000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,134000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,175000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,14899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1714000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2099000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18543000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,37255000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,37255000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26376000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103660000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60812000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-69224000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-69224000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-182000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,951000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9631000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-460000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22029000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,131000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,670000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,37374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2463000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12667000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,36294000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,36294000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9804000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-74026000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,66622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-184000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-14250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-14434000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-14434000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,278000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4930000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,479000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,24503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2857000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4509000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,43157000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,43157000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14271000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57908000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28794000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-43385000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-43385000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-193000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1063000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-346000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,566000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,129000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,105000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2780000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11962000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,28508000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,56696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,56696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26493000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,52679000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51714000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51714000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1746000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5966000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,43000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,261000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,36847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2905000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11963000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,56399000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,56399000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5295000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-121974000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58814000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-68455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-68455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1331000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1220000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1978000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7527000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3796000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,90066000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90066000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2959000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13330000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-59361000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,46631000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,46631000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25868000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75782000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34767000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34767000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-61800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-61800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-61800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1285000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18313000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2956000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,50127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3388000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-485000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17049000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9519000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,60560000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,60560000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98514000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,61062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49650000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49650000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1375000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2747000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4122000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4122000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,62000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15094000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,574000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,44863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44863000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3589000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-796000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17108000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9851000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,74615000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,74615000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-147799000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,90105000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-65818000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-65818000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1117000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,118000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7799000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,970000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,73960000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73960000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4185000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-18182000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11528000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,70391000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,70391000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8535000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-132156000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,104937000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35754000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35754000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1676000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1343000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3019000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3019000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-816000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36840000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,790000.0
